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The vasorelaxant effects of acetate: Role of adenosine, glycosis, lyotro-
pism, and pH and Ca12. The mechanism of acetate vasorelaxation is
unknown. In the rat caudal artery, acetate has a vasorelaxant effect and
also increases cyclic AMP. Here we evaluate the role of adenosine, of
possible glycolysis inhibition by acetate, of the lyotropic properties of
acetate and other anions, and of intracellular calcium and pH. Adeno-
sine per se did not relax the caudal artery in the range of 10—8 to 10_2
M. Preincubation with adenosine deaminase (ADA, 5.0 U/mI) or with
8-phenyltheophylline (8-PT, 1O_6 to 10" M) increased, rather than
blocked the vasorelaxant effect of acetate. Oxypurinol (l0— M) or the
nucleoside transport inhibitor NBMPR (l0- ss) had no effect on acetate
relaxation. Whereas acetate increased tissue cyclic AMP content, iO
si adenosine or 10_6 si PIA had no effect. In strips studied under
conditions of inhibited glycolysis (no glucose, with 11 mss 2-deoxyglu-
cose, 1.0 mM pyruvate, and 0.5 mat 5-iodoacetate), acetate-induced
relaxation, as well as acetate-induced cyclic AMP generation, tended to
be reduced but not significantly so. Other anions relaxed vascular strips
in relation to their lyotropic number, but only at higher doses, and they
did not stimulate cyclic AMP formation. Acetate (10 mM) caused a
transient fall in Ca12 followed by a slight, sustained rise. A concomi-
tant decrease in pH, was seen. DIDS, which blocks the relaxant and
cyclic AMP effects of acetate, had no effect on the pH decrease, but did
decrease the rate of pH1 recovery. Our results suggest that neither
adenosine generation nor inhibition of glycolysis (nor the lyotropic
property of acetate) mediate its vasorelaxant or cyclic AMP effects in
the rat caudal artery. Changes in pH or Ca12 are probably also not
involved.
Acetate is of hemodynamic importance in several physiologic
and pharmacologic settings. Acetate plays an important role in
digestion. In the gut, concentrations of short-chain fatty acids
as high as 75 mr,i are often achieved [1]; these short chain fatty
acids have important trophic effects on the colonic mucosa [2]
and they may also affect regional blood flows [1]. Acetate may
be important in the hemodynamic effects of exercise; in exer-
cising muscle, tissue acetate levels are increased [31.Acetate, a
metabolite of ethanol, may also play a role in the increased
splanchnic blood flow observed after ethanol ingestion [4]. Last
but not least, substantial plasma acetate levels (3 to 12 mM)
develop during hemodialysis using an acetate-containing dialy-
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sis solution [5]; during such dialysis, hypotension due to a
reduced peripheral vascular resistance is often encountered
[6-81.
Acetate causes depression of tension in some [9—12] but not
all [13] types of vascular smooth muscle. The mechanism of
acetate action is not known. We have studied acetate effects
primarily in the rat caudal artery, where we found acetate-
induced vasorelaxation to be associated with a rise in tissue
cyclic AMP levels [14, 15].
One hypothesis, proposed by Liang and Lowenstein [16] is
that the action of acetate is related to adenosine. They based
this thinking on a finding of increased cardiac levels of adeno-
sine and elevated muscle levels of adenosine monophosphate
(AMP) during acetate infusion. The thiokinase reaction, which
converts acetate to acetyl CoA, concomitantly generates AMP
from ATP. This AMP would then be converted to adenosine via
5'-nucleotidases, and the adenosine would be responsible for
the vascular effects of acetate [16, 17]. Indeed, adenosine
receptors are present in many types of vascular smooth muscle,
and do often mediate a vasorelaxant response [18, 19]. Adeno-
sine can either inhibit or stimulate cyclic AMP in various
vascular tissues [20—22]. Conceivably, our findings of acetate-
induced increases in cyclic AMP in the rat caudal artery might
be mediated via adenosine. One purpose of our study, then, was
to examine the relationships among adenosine, acetate-medi-
ated increases in cyclic AMP, and acetate-mediated vasorelax-
ation in our rat tail artery model.
The effects of acetate on intermediary metabolism have been
studied primarily in the heart; in cardiac tissue acetate exposure
results in a prompt cessation of glycolysis [23], believed to be
mediated through feedback inhibition of phosphofructokinase
by citrate, a condensation product of acetyl CoA in the Krebs
cycle [24, 25]. Because changes in energy metabolism in vas-
cular smooth muscle have been linked to tension [26], a second
goal of our study was to determine whether or not the vasore-
laxant effect of acetate might be due to glycolysis inhibition or
to sudden provision of additional oxidizable substrate to tissues
previously limited to glucose.
Acetate, as an anion, has lyotropic properties [27], and in
preliminary work we found that, at a concentration of 16 ma'i,
various anions added to the tissue bath did cause vasorelaxation
in our model in relation to their lyotropic numbers [14] (the
lyotropic number of an anion is related to its abilities to salt out
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albumin [27]). In the present study we extended these observa-
tions to more fully characterize this vasorelaxant anion effect.
Because in some tissues various anions have been shown to
stimulate cyclic AMP [28—30], and because we found that
acetate increased tissue levels of cyclic AMP [14], we also
determined the effect of anion substitution or addition on tissue
levels of cyclic AMP and GMP in our model.
Furchgott and Wales speculated that acetate might be acting
via intracellular acidification [31], and indeed, acetate has been
used as a probe to reduce intracellular pH [32]. Because
intracellular acidification associated with sudden increases in
perfusate CO2 level has been associated with vasorelaxation
[33, 34], we also studied the effects of acetate on pH1 and Ca12
in cultured rat aortic vascular smooth muscle cells.
Methods
Selection and preparation of animals
All studies in the rat caudal artery were performed in male
Wistar rats weighing between 250 and 500 g. Animals were
anesthetized by CO2 inhalation and then sacrificed by cervical
dislocation, after which the tail artery was removed. The
mid-region (6 to 10 cm long) was cut into cylinders (1.0—1.5 cm
in length) for study.
Experimental design
Tension studies. Short cylinders cut from the tail artery were
mounted in tissue bath chambers over a pair of fine metal wires.
Cylinders were studied after a two-hour incubation period in
physiologic salt solution (PSS) using a resting tension of 2.0 g.
Vascular rings were randomized into groups, constricted with 2
nM AVP, and then exposed to a "relaxation solution" which
contained the same concentration of AVP and the compound(s)
of interest. Tension, expressed as a percentage of that just prior
to exposure to the test solution, was assessed over time. The
tension five minutes after exposure to the test solution was
analyzed.
In one protocol, tail rings were randomized into six groups:
control and adenosine, 108, 10-6, l0—, l0, or l0_2 M. The
adenosine-containing solutions, also containing AVP, were
substituted during the plateau (at 5') of the AVP contraction.
The purpose of these studies was to determine whether or not
adenosine per se had any vasorelaxant effect against AVP in our
preparation.
In another protocol, also a randomized design, tail rings from
two rats each were randomized into 12 groups: control and
adenosine 10-8 through 10_2 M, with and without l0— U/ml
insulin. In these studies, adenosine and/or insulin were added to
the baths beginning 60 minutes prior to the AVP contraction,
and also to the "relaxation solutions"; the latter contained 16
m acetate for each group. The purpose of these studies was to
determine whether or not adenosine and/or insulin pretreatment
had any effect on acetate-induced relaxation.
A third protocol was a paired design. Each ring underwent
two cycles of AVP-contraction/test-solution relaxation: in the
first cycle the relaxation solution contained 16 m acetate and
no other test compound; in the second cycle the test compound
was introduced 30 minutes prior to AVP contraction, and was
also present in the solution during the AVP contraction and in
the relaxation solution (16 m acetate). The purpose was to
determine whether any of the test compounds affected acetate-
mediated vasorelaxation.
In a fourth protocol, a 4 m acetate relaxation solution was
used, but in one-half of the groups, all solutions contained 11
mM 2-deoxyglucose, 0.5 mrvi iodoacetate, and 1.0 mM pyruvate
and no glucose, begun one hour prior to the test AVP contrac-
tion. This solution has been shown to suppress glycolysis in the
rat caudal artery model [35]. The purpose of this experiment
was to evaluate the effect of suppressing glycolysis on acetate-
induced relaxation.
A fifth protocol tested the effects of lyotropic anions. Rats
were randomized into eight groups, a control group and seven
groups corresponding to six anions: fluoride, iodate, sulfate,
bromate, bromide, nitrate, and thiocyanate. The lyotropic
numbers of these anions, a function of their ability to salt out
albumin from solution, were as follows: fluoride 4.5, iodate 6.0,
sulfate 7.5, bromate 9.0, bromide 11.4, nitrate 11.8, thiocyanate
13.2. The lyotropic number of chloride, the anion being re-
placed, is about 10.0. The lyotropic number of acetate has been
measured to be about 9.0 [27]. In each rat eight cylinders were
cut from the caudal artery, and randomized to anion dose
(control, 2, 4, and 16 mM) and method of addition (isosmotic,
that is, substituted for chloride, or hyperosmotic, added to
chloride). All anions used were in the form of sodium salts. The
relaxation solution containing the anion was added at 5' after
the onset of an AVP contraction (2 nM), during the plateau
phase. The vasorelaxant effects against AVP were then plotted
for each anion as a function of its lyotropic number, both during
isosmotic and hyperosmotic conditions.
Cyclic AMP studies. All studies were done in untensioned
tissue in the form of artery cylinders. For each experiment, ito
1.5 cm cylinders were prepared from the mid-section of each
tail artery and were incubated in physiologic salt solution (PSS)
at 37°C for two hours, changing the bath at 30 minute intervals.
Usually about six cylinders were cut from each tail and were
randomized into experimental groups. Although the cyclic
AMP study design was set to parallel the tension studies, AVP
was not added to the tissue bath, as we found that its addition
or omission did not affect the cyclic AMP results [36].
The purpose of these studies was to determine whether or not
adenosine would increase tissue cyclic AMP content in the rat
caudal artery. The design was similar to that reported previ-
ously in which it was established that acetate increased cyclic
AMP in this tissue. In the presence of l0 M isobutylmethyl-
xanthine (IBMX), tissue cyclic AMP content was evaluated in
control strips versus in those incubated for two minutes in
M adenosine in 10-6 M PIA, or in 4 m acetate.
In additional experiments, the effects of addition of various
anions (16 mM) on cyclic AMP and cyclic GMP formation was
evaluated. Cyclic AMP was measured in IBMX, two minutes
after anion addition or substitution for an equivalent amount of
chloride.
Solutions. The control tissue bath solution (PSS) contained
25 mrvi HCO3, 140 m'vi sodium, 1.4 mrvi calcium, 0.7 mM
magnesium, 5.0 potassium, 124 chloride, and 11 m dextrose.
Throughout the experiments the PSS solution was gassed with
95% 02 and 5% CO2. The solution was kept at 37°C at all times
except during preparation and cutting of the tissue, when the
solution used was kept at room temperature. Isosmotic solu-
tions (calculated osmolality) containing 16 m acetate were
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prepared by substituting the appropriate amounts of sodium
acetate for sodium chloride.
Laboratory methods
Cyclic nucleotide extraction. Enzymes in the crush-frozen
tissue were permanently inactivated and tissue protein precip-
itated by homogenizing the tissue in 10% trichloroacetic acid
(TCA) at 0°C in a ground glass homogenizer tube. The precip-
itated protein was pelleted by centrifugation at 3200 RPM for 30
minutes. After centrifugation the supernatant was saved for
cyclic nucleotide determination, and the protein content of the
tissue pellet was determined (after solubilization in 1.0 N
NaOH) by the Lowry method. Residual TCA in the supernatant
was protonated with 0.1 N HC1 and extracted five times using
hydrated ether. After extraction, the acid in the sample was
neutralized with NaOH, and a sodium acetate buffer at pH 6.2
was added.
Cyclic nucleotide determination, cAMP and GMP levels in
the supernatants were measured by radioimmunoassay as pre-
viously described [14, 15], using I'25-tagged cAMP or cGMP
(Biomedical Technologies, Inc., Stoughton, Massachusetts,
USA) as probes [5, 6]. cAMP antibody was obtained from
Research Products International (Mount Prospect, Illinois,
USA), and cGMP antibody from Meloy Laboratories (Spring-
field, Virginia, USA). Prior to assay, the samples were acety-
lated using triethylamine and acetic anhydride in order to
increase assay sensitivity. Precipitation of antibody-antigen
complexes was by addition of gamma-globulin and cold isopro-
panol.
Cell culture
Vascular smooth muscle cells were obtained from the tho-
racic aorta of male Wistar rats and isolated by collagenase and
elastase digestion [37—39]. Cells were seeded onto 9 X 35 mm
coverslips (Wheaton Glass) resting in a 60 mm tissue culture
dish. One aorta was used per culture. The cells were grown in
Dulbecco's modified Eagle's medium supplemented with
Ham's F12 nutrient (Sigma Chemical Co., St. Louis, Missouri,
USA), 10% fetal calf serum (Hazleton), penicillin (100 U/ml),
streptomycin (100 g/ml) and Fungizone (250 .tg!ml) at 37°C in
a humidified atmosphere of 5% CO2. Cultures were fed or
passaged twice weekly, Vascular smooth muscle cells were
characterized by light microscopy as previously described.
Experiments were performed on confluent subcultures be-
tween the second and tenth passages obtained from primary
cultures. Twenty-four to 48 hours prior to the study, the cells on
coverslips were fed with serum-free media and the cells remain-
ing adherent to the culture dish were passaged onto fresh
coverslips. The subcultures grew to confluency in five to seven
days.
Dye loading and superfusion
On the day of the study, cells were loaded with either 4 M
fura-2 AM or 1.5 M BCECF-AM for 30 minutes at 37°C. The
coverslips were then washed three times with the assay buffer
and allowed to sit for at least 15 minutes before beginning the
experiment. Neither fura-2 nor BCECF loading altered vascular
smooth muscle cell morphology as assessed by light micros-
copy. At the start of the experiment a coverslip was placed in a
customized holder and inserted into a suction cuvette (Helma)
resting in a water-jacketed cuvette holder. The temperature was
maintained constant at 37°C. The coverslips were then super-
fused at a rate of 2 mI/mm with the prewarmed assay buffer
using a syringe pump, and the effluent was constantly removed
with a peristaltic pump. When experimental solutions were
switched during the course of an experimental maneuver, the
superfusion rate was increased to 8 ml/min for 30 seconds to
enhance the rate of exchange. Preliminary experiments demon-
strated that at this rate, there was a greater than 95% exchange
of solutions within 20 seconds. The contribution of external
fura-2 or BCECF to the total fluorescent signal due to dye
leakage was found to be negligible at the rate of superfusion
used as demonstrated by the lack of fluorescence of either dye
in the effluent. All solutions and experimental agents were
measured for intrinsic fluorescence and these values were
subtracted from total fluorescence prior to calculating Ca2.
None of the solutions affected the calculation of pH, at the
wavelengths used for BCECF.
Method of calculating Ca
Fura-2 fluorescence was measured using a Perkin-Elmer LS-5
spectrofluorometer (Perkin-Elmer, Norwalk, Connecticut, USA)
connected to an IBM PC-XT computer programmed to rapidly
alternate between the desired excitation wavelengths (340 and 380
nm) for fura-2 loaded cells [37]. The emission wavelength (510 nm)
was constant. The excitation and emission slits were set at 5 and
10 nm, respectively. Free cytosolic Ca2 was calculated using the
formula described by Grynkiewicz, Poenie and Tsien [40],
RRmin SfCa•2= x—xKdRmaxR Sb
where R was the 340/380 nm ratio of the fluorescence signal.
Rmax was the 340/380 ratio in the presence of saturating Ca2,
Rmin was the 340/380 ratio in Ca2-free media with 10 mM
EGTA added, and Sf/Sb was the ratio of the 380 nm fluores-
cence measured in a Ca2-free solution to that measured in a
Ca2treplete solution. The calibration parameters were ob-
tained in a separate set of experiments using fura-2 acid in a
solution designed to simulate the cytosol. Rmin was determined
in a solution of 10% glycerol containing (mM): KC1 115, NaCl
10, MgSO4 2.0, K2H2EGTA 10, and MOPS (K2-[N-mor-
pholino]-propane sulfonic acid) 10, at a pH of 7.2. For the
determination of Rmax, 2.0 mM CaC12 was added and CaEGTA
was substituted for K2H2EGTA. The calibration values so
determined were 6.98, 0.79, and 4.19 for Rmax, Rmin, and Sf/Sb,
respectively 1371.
The value for the fura-2 Kd for calcium used in the Ca12
equation above was 224 nm, which is the Kd determined by
Grynkiewicz et al [40]. Corrected values for Ca2, based on the
relationship between fura-2 Kd for calcium and pH described
by Negulescu and Machen [41], were also calculated. Negu-
lescu and Machen [41] also found that in the alkaline pH range,
little correction of the fura-2 Kd was required, but that during
intracellular acidosis, the measured increase in Ca2 could be
underestimated due to large increases in the fura-2 Kd value.
Method of calculating pH,
BCECF fluorescence was measured in a similar fashion,
alternating between the desired excitation wavelengths (500 and
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Fig. 2. Effect of preincubation with adenosine, 8-phenyitheophylline
(10- M), or adenosine deaminase (5.0 U/mI) on acetate-mediated (16
mM) relaxation of an AVP (2 nM) contraction. Symbols are: () first
relaxation (in control PSS); () second relaxation (in study solution).
As shown, adenosine preincubation reduced the amount of acetate
relaxation, whereas 8-phenyltheophylline and adenosine deaminase
both accentuated, rather than blocked, the vasorelaxant effect of
acetate (N = 12 per group).
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Fig. 1. Effects of adenosine on a 2 nM AVP contraction. A solution
containing 2 nM AVP and the concentration of adenosine shown was
introduced into the bath during the plateau phase (5 mm after introduc-
tion of AVP) of the AVP contraction. As shown, neither a constrictor
nor a relaxant effect was found at any adenosine dose level (N = 6 per
group).
440 nm) with an emission wavelength of 510 nm. The excitation
and emission slits were set at 5 and 10 nm, respectively. To
calculate the pH1, the 500/440 BCECF ratio was calibrated using
nigericin (6 pg/mI) in 120 mivt K buffer as previously described
[37, 421. The pH of the superfusate was adjusted in a stepwise
fashion between 6.4 and 7.8 by progressive addition of NaOH.
Experimental design for pH, and Ca, studies
All experiments were performed in C02/HC03 buffered
solutions. The standard HC03 solution contained (in mM):
Na 136; K 4.7; C1 122; HC0 22; Ca2 1.25; Mg2 1.25;
HPO4 0.97; H2P04 0.23; glucose 3.0; and HEPES 5.0, and was
equilibrated with 5% C02/95% 02. The pH of this solution was
7.40.
The effects of introduction of 10 mM sodium acetate were
studied. Effects of pH, and on Ca2 were determined in parallel
experiments. In additional studies, the effect of pretreatment
with l0 M DIDS on the pH1 changes was also determined. We
have shown previously that DIDS completely blocks both the
vasorelaxant and cyclic AMP effects of acetate in the rat caudal
artery [14]. We did not expect DIDS pretreatment to affect pH1
changes induced by acetate, as these purportedly are due to
proton entry into the cell via non-ionic diffusion of acetic acid
[43]. However, we performed the DIDS experiments anyway,
reasoning that if the pH1 changes were preserved, as expected,
then any postulated link between the pH1 effects of acetate and
the vasorelaxant or cyclic AMP effects would be effectively
disproved.
Statistical analysis
Results were analyzed using analysis of variance and cova-
riance. The statistical importance of differences between group
means was assessed using the Tukey B procedure. Values of P
<0.05 were judged to be statistically significant. All results are
listed as mean 1 SEM.
Chemical sources and solutions
Adenosine deaminase (bovine intestine) was obtained from
Calbiochem, La Jolla, California, USA. Arginine vasopressin
was obtained from Bachem, Torrance, California, USA. All
other compounds were obtained from Sigma Chemicals. All
compounds were dissolved in ultrapure water prior to use.
8-Phenyitheopylline was prepared as a stock solution by dis-
solving 6.4 mg in 10 ml of an ethanol/sodium hydroxide solu-
tion.
Nigericin was obtained from Sigma Chemical. BCECF/AM
and fura-2/AM were purchased from Molecular Probes, Inc.
(Eugene, Oregon, USA).
Results
Vascular effects of adenosine
As shown in Figure 1, adenosine had neither a sustained
constrictor nor relaxant effect in the rat caudal artery. In some
animals, a transient constrictor response was seen when aden-
osine was added to the AVP-contracted tissue, but this was
difficult to separate from the transient artifact due to changing
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Fig. 4. Effects of acetate (4 mM), adenosine (IO M), and L-phenyl-
isopropyladenosine (PIA, iO- Al) on tissue cyclic AMP content in rat
candal artery cylinders. Tissue cyclic AMP levels were assayed after
two minutes of incubation in the test solutions. All solutions also
contained lO— at IBMX. As shown, whereas acetate increased tissue
cyclic AMP content, adenosine and PTA had no effect.
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Fig. 3. The same protocol as in Figure 2. Symbols are: (U) first
relaxation (in control PSS); () second relaxation (in study solution).
This time, the effects of preincubation with inosine (l0 M) or
oxypurinol (l0- M) on acetate (16 mM) relaxation of an AVP (2 nM)
contraction were evaluated. Neither compound affected acetate-in-
duced vasorelaxation. Results of pretreatment with nitrobenzylthioino-
sine (l0 M), a blocker of nucleoside translocation, are also shown.
These were also negative.
the bath composition. In all cases, at five minutes after adeno-
sine addition, AVP-induced tension was unchanged.
Effect of adenosine on acetate-induced vasorelaxation
Pretreatment of vascular rings with IOto lO_2 ai adenosine
had no significant effect on acetate-induced vasorelaxation,
whether or not insulin was present (data not shown).
Effect of various adenosine-rela ted compounds on acetate-
induced vasorelaxalion
Figures 2 and 3 show the results of the paired design, where
two sequential relaxations to 16 m acetate were studied, with
the second relaxation done after pretreatment with the test
agent, As shown in Figure 2, the amount of relaxation was
equivalent in the control condition studying two sequential
relaxations. Pretreatment with adenosine (l0— M) in the paired
design resulted in slight inhibition of acetate-induced relaxation
(Fig. 2). Both 8-phenyltheophylline and adenosine deaminase
pretreatment magnified the amount of acetate-induced vasore-
laxation, a finding opposite to that which one would expect if
the acetate effect was being mediated via adenosine (Fig. 2).
The acute addition of 8-phenyltheophylline or adenosine deam-
inase per se did not relax a 2 nat AVP contraction (data not
shown). Inosine was tested because of reports that in some
vascular tissues, intracellular effects of adenosine might be
mediated by its metabolite, inosine [44]. As shown in Figure 3,
inosine pretreatment did not have any effect on the magnitude
of acetate-induced vasorelaxation. Oxypurinol was evaluated to
stop free radical generation via xanthine oxidase from increased
metabolism of adenosine [45]. Superoxide causes endothelial-
mediated injury and vasoconstriction [46], hence, one possible
result might have been an accentuation of acetate vasorelax-
ation by oxypurinol pretreatment. However, as shown in Figure
4, there was no effect of oxypurinol on acetate-induced vasore-
laxation.
Effect of adenosine-related compounds on cyclic AMP
As shown in Figure 4, whereas 4 m acetate caused a marked
increase in tissue cyclic AMP levels, confirming previous
findings [14, 15], addition of adenosine l0—, adenosine mono-
phosphate l0- M, or phenylisopropyladenosine 106 M, had no
effect.
Effects of pretreatment with iodoacetate, pyruvate, and 2-
deoxy glucose on acetate-vasorelaxation
As shown in Figure 5, the baseline tension developed after 2
n AVP was almost doubled when strips were preincubated in
the iodoaeetate/pyruvate/2-deoxyglucose solution. The amount
of acetate-induced relaxation tended to be reduced slightly,
especially when the data were expressed as (%) of original
tension. However, acetate-induced vasorelaxation was by no
means abolished.
The related cyclic AMP experiments are shown in Figure 6.
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Fig. 5. Effect on acetate relaxation of preincubating rat caudal artery
cylinders in a glucose-free PSS solution containing pyruvate, 2-deoxy-
glucose, and 5-iodoacetate (to inhibit glycolysis and to allow for
pyruvate oxidation during the baseline conditions). Symbols are: (•)
iodoacetate control; (U) iodoacetate + 4 m acetate; (•) PSS control;
(0) acetate 4 m. The preincubation conditions markedly accentuated
the magnitude of a 2 nM AVP contraction. Whereas the relaxant effect
of acetate (4 mM) was not prevented, it was reduced if the data were
calculated as (%) relaxation (N = 8 per group).
Acetate (4 mM) increased tissue cyclic AMP levels significantly
in both control vessels and in vessels preincubated with iodo-
acetate/pyruvate/2-deoxyglucose.
Effect of lyotropic anions
Data are shown in Figures 7 and 8. There was some vasore-
laxant effect of the anions tested, especially those with lyotro-
pic numbers below 10, although this effect was pronounced only
at a concentration of 16 mrs'i. In contrast, anions with lyotropic
numbers greater than 10 tended to increase an AVP contraction
slightly. As shown in Figure 8, there was no increase in tissue
cyclic AMP levels with any of the anions tested, and there was
a trend for cyclic GMP levels to be increased only by fluoride.
Effects of acetate on pH, and Ca/
These are shown in Figures 9 and 10. As shown in Figure 9,
introduction of 10 ifiM acetate resulted in a transient fall in pH1,
from 7.36 0.01 to 7.23 0.003 units. During the subsequent
10 rinutes pH1 recovered fully to baseline. Concomitantly, with
the introduction of acetate there was a transient slight fall in
Ca12, from 155 7.7 n to 149 5.2 n. This was followed by
a prompt increase in Ca2 to slightly above baseline values, 164
5.6 nM. In parallel experiments in which the effect of DIDS
pretreatment was assessed, the introduction of l0— M DIDS
per se caused a slight fall in pH1, from 7.34 0.02 to 7.31
0.02. Introduction of 10 m acetate in the continued presence
of DIDS was associated with a pronounced acidification, to 7.18
DIDS was impaired, and recovery was absent, even 10 minutes
after the start of acetate exposure (Fig. 10).
Discussion
Our results are primarily negative, suggesting that a number
of postulated mechanisms for acetate action may not be in-
volved in the rat caudal artery. The first system that was
examined was that of adenosine. We found that adenosine per
se had no relaxant effect in the rat caudal artery and that
adenosine pretreatment had little effect on acetate induced
vasorelaxation. Blocking adenosine receptors with 8-phenylthe-
ophylline augmented the vasorelaxant effect of acetate rather
than blocking the acetate effect, as is the case in vivo in the rat
splanchnic vasculature [4] or in coronary vessels [12]. Pretreat-
ment with adenosine deaminase augmented the acetate vasore-
laxant response. If one were to assume that acetate caused
vasorelaxation by generating adenosine intracellularly, which
then exited the cell and acted on cell surface receptors, one
would expect deaminase treatment to block acetate induced
vasorelaxation. If the effects of acetate are not mediated by
adenosine in this tissue, then how does one explain the aug-
mentation of effect by 8-phenyltheophylline or by adenosine
deaminase? One possibility is that adenosine was exerting a
slight tonic constrictor response in this tissue, as reported by
others [47], Other possibilities include the fact that 8-phenyl-
theophylline, once thought to be a relatively specific adenosine-
receptor blocker with little effects on phosphodiesterase, actu-
ally can have marked effects on cyclic AMP hydrolysis [48].
Adenosine deaminase might have augmented acetate-induced
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Fig. 6. Effect on acetate-induced cyclic AMP accumulation of prein-
cubating rat caudal artery cylinders in glucose-free PSS containing
pyruvate, 2-deoxyglucose, and 5-iodoacetate. Symbols are: (0) con-
trol; () acetate 4 ms. Acetate (4 mM) increased tissue cyclic AMP
levels under both conditions (N = 8 per group).
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0.03 units. Interestingly, pH1 recovery in the presence of relaxation by virtue of the fact that many preparations have
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Fig. 7. Effect of various anions on a 2 nM AVP contraction. The
relaxation solution containing 2 nri AVP and also containing the test
anion [either substituted for chloride (•), or added (0), always as the
sodium salti was introduced 5 minutes into an AVP (2 nM) contraction.
The anions tested (with lyotropic numbers obtained from the literature
in parentheses) were: fluoride (4.5), iodate (6.0), sulfate (7.5), bromate
(9.0), bromide (11.4), nitrate (11.8), and thiocyanate (13.2). As shown,
at the higher dose levels, there appears to be some relationship between
anion lyotropic number and the effect on tension; anions with low
lyotropic numbers tended to relax the AVP contraction, whereas anions
with high numbers caused further constriction (N = 7 to 10 per group).
been shown to be contaminated with superoxide dismutase,
which can cause increased cyclic lIMP formation [49]. Despite
the caveats of using 8-phenyitheophylline or adenosine deami-
nase, these compounds failed to block acetate-relaxation at any
dose level, an unlikely finding if the vasorelaxant effect of
acetate in this tissue were being mediated by adenosine.
Adenosine was not responsible for the increase in tissue
cyclic AMP levels effected by acetate, as neither the parent
Anion lyotropic number, 76mM
Fig. 8. Effect of various anions (16 mM) on tissue levels of cyclic AM)
(U) andcyclic UMP (U). The anions tested were the same as those ii
Figure 6. As shown, none of the anions had any significant effect oi
tissue cyclic nucleotide levels at the dose tested (N = 8 per group). Thi
bars represent control values.
compound nor phenylisopropyl adenosine (PIA), an analogin
limited to the extracellular space, increased tissue cyclic AMI
levels. Because adenosine is known to increase cyclic AMI
formation via activation of A2 receptors in a number of tissue!
[20, 221, our results suggest that one needs to look elsewhere foi
the mechanism of the cyclic AMP increase in response tc
acetate [14] and other short chain fatty acid salts [15].
Acetate metabolism can have a profound inhibitory effect oi
glycolysis, the usual mechanism being thought to be feedbacl
inhibition of phosphofructokinase via citrate formed from oxi
dation of acetyl CoA in the Krebs cycle [24, 25]. We attempte
to inhibit glycolysis by putting 2-deoxyglucose instead of glu
cose into the bathing solution, as well as 5-iodoacetate to caus
inhibition of phosphofructokinase by formation of isocitrate
We added pyruvate to the bathing solution to allow the tissue tc
obtain its energy from pyruvate oxidation [35]. Under thes
conditions the vasorelaxant effect of acetate was not abolished
suggesting that a shift from anaerobic to aerobic metabolisn
was also not the means whereby acetate was causing vasore
laxation.
We also explored the possibility that the vasorelaxant effec
of acetate in this tissue might be a non-specific effect, due to th
lyotropic properties of the acetate anion. Evaluation of a pane
of anions, grouped according to their lyotropic numbers, failec
to reproduce the vasorelaxant effects of acetate at the dos
levels used. At the lyotropic range of 9 to 10, where acetat
falls, there was no vasorelaxant effect (Fig. 7). None of th
anions tested at any dose reproduced the effects of acetate oi
tissue cyclic AMP levels.
Finally, we examined the initial hypothesis proposed b
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B 200
Fig. 9. Effect of exposure to 10 m acetate on (A) pH1 and (B) Ca in
rat aortic vascular smooth muscle cells. A prompt fall in pH1 occurs,
which then resolves to baseline within 10 minutes. There is a very
transient fall in Ca12 which then increases to above baseline. The
heavy broken line shows Ca2 values corrected for the effects of pH on
the fura-2 Kd for calcium.
Fig. 10. Effect of exposure to 10 mM acetate on pH1 in cells pretreated
with io MDIDS. Compare with Figure 9. DIDS pretreatment accen-
tuated the fall in pH1 slightly, and prevented the restoration of pH1 to
baseline. N = 5.
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